drugset / Trial / NCT00741767

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD

NCT00741767

RandomizedCrossoverQuadruple-blind

Summary

The purpose of this study is to determine if Advair Diskus improves sleep quality by reducing lung hyperinflation in COPD.

Timeline

Start
2008-08
Primary completion
2010-09
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 50 ug Inhaled
Subject Salmeterol Other / unclassified 250 ug Inhaled